tamibarotene has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumabe, T; Nishihara, M; Saito, R; Satoh, T; Sonoda, Y; Sugiyama, S; Tominaga, T; Yamashita, Y; Yokosawa, M; Yokoyama, M | 1 |
1 other study(ies) available for tamibarotene and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Benzoates; Brain Neoplasms; Cell Survival; Convection; Dacarbazine; Drug Delivery Systems; Glioblastoma; Humans; Longevity; Male; Micelles; Polymers; Rats; Rats, Inbred F344; Rats, Nude; Rats, Sprague-Dawley; Retinoids; Temozolomide; Tetrahydronaphthalenes; Xenograft Model Antitumor Assays | 2010 |